ProShare Advisors’s BioNTech BNTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $397K | Sell |
3,730
-758
| -17% | -$80.7K | ﹤0.01% | 1252 |
|
|
2025
Q1 | $409K | Sell |
4,488
-164
| -4% | -$14.9K | ﹤0.01% | 1205 |
|
|
2024
Q4 | $530K | Sell |
4,652
-1,141
| -20% | -$130K | ﹤0.01% | 1239 |
|
|
2024
Q3 | $688K | Sell |
5,793
-260
| -4% | -$30.9K | ﹤0.01% | 955 |
|
|
2024
Q2 | $486K | Sell |
6,053
-732
| -11% | -$58.8K | ﹤0.01% | 993 |
|
|
2024
Q1 | $626K | Buy |
6,785
+637
| +10% | +$58.8K | ﹤0.01% | 965 |
|
|
2023
Q4 | $649K | Buy |
6,148
+40
| +0.7% | +$4.22K | ﹤0.01% | 893 |
|
|
2023
Q3 | $664K | Buy |
6,108
+57
| +0.9% | +$6.19K | ﹤0.01% | 813 |
|
|
2023
Q2 | $653K | Sell |
6,051
-432
| -7% | -$46.6K | ﹤0.01% | 845 |
|
|
2023
Q1 | $808K | Sell |
6,483
-1,123
| -15% | -$140K | ﹤0.01% | 762 |
|
|
2022
Q4 | $1.14M | Buy |
7,606
+193
| +3% | +$29K | ﹤0.01% | 715 |
|
|
2022
Q3 | $1M | Buy |
7,413
+550
| +8% | +$74.2K | ﹤0.01% | 731 |
|
|
2022
Q2 | $1.02M | Sell |
6,863
-2,257
| -25% | -$336K | ﹤0.01% | 755 |
|
|
2022
Q1 | $1.56M | Sell |
9,120
-3,288
| -26% | -$561K | ﹤0.01% | 785 |
|
|
2021
Q4 | $3.2M | Sell |
12,408
-5,150
| -29% | -$1.33M | 0.01% | 666 |
|
|
2021
Q3 | $4.79M | Buy |
17,558
+3,309
| +23% | +$903K | 0.01% | 525 |
|
|
2021
Q2 | $3.19M | Buy |
14,249
+3,859
| +37% | +$864K | 0.01% | 605 |
|
|
2021
Q1 | $1.13M | Buy |
10,390
+151
| +1% | +$16.5K | ﹤0.01% | 915 |
|
|
2020
Q4 | $835K | Buy |
+10,239
| New | +$835K | ﹤0.01% | 964 |
|